Assistant Professor (WOT) in Medical Oncology

The Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting a full-time faculty member at the Assistant Professor level without tenure due to funding (WOT), commensurate with experience and qualifications in the Clinical Research Division of the Fred Hutch and the Division of Medical Oncology, Department of Medicine at the UW. This position would have an annual service period of 12 months [July 1-June 30]. The primary appointment will be in the Clinical Research Division of Fred Hutch. The selected individual for the advertised position is expected to contribute to our mission of delivering outstanding clinical care and developing excellence in clinical research. We seek a laboratory-based scientist to conduct innovative, independent, and collaborative basic or translational research focused in immunotherapy.

Fred Hutch and University of Washington faculty engage in teaching, research, and service. Teaching responsibilities will involve oversight of advanced practice providers and fellows during inpatient and outpatient rotations, and delivery of informal teaching sessions and formal lectures to providers and the general medical community.

The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Fred Hutch, together with the University of Washington, Seattle Children’s, and the Seattle Cancer Care Alliance, is an NCI-designated Comprehensive Cancer Center with active training programs for graduate students and postdoctoral fellows. In addition, Fred Hutch has outstanding facilities and cutting-edge shared resources to support faculty success. Collaborative opportunities exist for joint and/or affiliate appointments in the Fred Hutch Divisions of Public Health Sciences, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, as well as the University of Washington, depending upon candidate interest and qualifications.

At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion. 

Anticipated start date would be June 1, 2022.

Applicants must have an MD degree (or foreign equivalent) and board certification in Medical Oncology or Hematology (or foreign equivalent). 

Must have a record of research in molecular and genetic determinants of lung cancer initiation and progression, therapeutic resistance to targeted- and immune based therapies, tumor-initiating lung epithelial cell populations, lung cancer early detection, or a related area. Positive factors for consideration include, but are not limited to, a record of research focusing on melanoma and/or lung cancer.

In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) or equivalent as determined by the Secretary of Health and Human Services.  

Interested candidates should submit a curriculum vitae, a concise research statement, a diversity statement describing your past contributions to diversity, equity, and inclusion and your future plans for continuing these efforts (two pages or less), and list of references, along with a letter of application addressed to Dr. McGarry Houghton.